Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Scientific Industries (SCND) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Scientific Industries (SCND) over the last 14 years, with Q3 2025 value amounting to $84400.0.

  • Scientific Industries' Gains from Investment Securities rose 343.14% to $84400.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $263600.0, marking a year-over-year decrease of 4795.66%. This contributed to the annual value of $1.8 million for FY2024, which is 6386.5% up from last year.
  • Per Scientific Industries' latest filing, its Gains from Investment Securities stood at $84400.0 for Q3 2025, which was up 343.14% from $82500.0 recorded in Q2 2025.
  • Scientific Industries' 5-year Gains from Investment Securities high stood at $1.1 million for Q4 2022, and its period low was -$441000.0 during Q2 2021.
  • Its 5-year average for Gains from Investment Securities is $75541.8, with a median of $56900.0 in 2022.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 93840.3% in 2021, then skyrocketed by 2835000.0% in 2022.
  • Over the past 5 years, Scientific Industries' Gains from Investment Securities (Quarter) stood at -$4200.0 in 2021, then soared by 26666.9% to $1.1 million in 2022, then tumbled by 76.92% to $257500.0 in 2023, then crashed by 69.86% to $77600.0 in 2024, then increased by 8.76% to $84400.0 in 2025.
  • Its last three reported values are $84400.0 in Q3 2025, $82500.0 for Q2 2025, and $19100.0 during Q1 2025.